Skip to main content
Top
Published in: Endocrine 2/2020

01-02-2020 | McCune-Albright syndrome | Original Article

A severe inactivating PTH/PTHrP signaling disorder type 2 in a patient carrying a novel large deletion of the GNAS gene: a case report and review of the literature

Authors: Alessandro Brancatella, Giovanna Mantovani, Francesca M. Elli, Simona Borsari, Claudio Marcocci, Filomena Cetani

Published in: Endocrine | Issue 2/2020

Login to get access

Abstract

Purpose

Pseudohypoparathyroidism (PHP), characterized by multihormone resistance and Albright’s hereditary osteodystrophy (AHO), is caused by GNAS mutations. Whole or partial gene deletions are rare. All disorders due to inactivating mutations of the GNAS gene are now classified as “inactivating PTH/PTHrP signaling disorder type 2” (iPPSD2). This study reports a family harboring a large GNAS gene deletion in order to improve the knowledge of genotype–phenotype correlation of this disease.

Methods

An 18-year-old man with severe diffuse soft ossifications and multihormone resistance underwent to clinical, biochemical, radiological, and genetic studies. A review of the literature of other cases of iPPSD2 due to GNAS large deletions was performed focusing on clinical and biochemical features.

Results

The proband presented signs of hypocalcemia and marked AHO features. Laboratory tests revealed hypocalcemia, high levels of serum phosphate, PTH, TSH, and calcitonin despite therapy with calcium carbonate, calcitriol, and levothyroxine. Diffuse soft tissue ossifications and brain calcifications were shown by radiological exams. Family history was remarkable for hypocalcemia, neurocognitive impairment, and cerebral calcifications in his brother and AHO features in the maternal grandfather. The proband’s mother showed short stature, whereas physical examination of the father was unremarkable. Genetic analysis of the GNAS gene revealed an unreported large deletion encompassing exons 1–7 in the proband, brother, and mother. By reviewing the literature, only six other cases were described.

Conclusions

We report a kindred harboring a large GNAS deletion. A genotype–phenotype correlation was observed in term of severity of tissue ossifications in the siblings but not in the mother.
Literature
1.
go back to reference M.C. Lemos, R.V. Thakker, GNAS mutations in pseudohypoparathyroidism type 1a and related disorders. Hum. Mutat. 36, 11–19 (2015)CrossRef M.C. Lemos, R.V. Thakker, GNAS mutations in pseudohypoparathyroidism type 1a and related disorders. Hum. Mutat. 36, 11–19 (2015)CrossRef
2.
go back to reference S. Thiele, G. Mantovani, A. Barlier, V. Boldrin, P. Bordogna, L. De Sanctis, F.M. Elli, K. Freson, I. Garin, V. Grybek, P. Hanna, B. Izzi, O. Hiort, B. Lecumberri, A. Pereda, V. Saraff, C. Silve, S. Turan, A. Usardi, R. Werner, G.P. de Nanclares, A. Linglart, From pseudohypoparathyroidism to inactivating PTH/PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP network. Eur. J. Endocrinol. 175, P1–P17 (2016)CrossRef S. Thiele, G. Mantovani, A. Barlier, V. Boldrin, P. Bordogna, L. De Sanctis, F.M. Elli, K. Freson, I. Garin, V. Grybek, P. Hanna, B. Izzi, O. Hiort, B. Lecumberri, A. Pereda, V. Saraff, C. Silve, S. Turan, A. Usardi, R. Werner, G.P. de Nanclares, A. Linglart, From pseudohypoparathyroidism to inactivating PTH/PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP network. Eur. J. Endocrinol. 175, P1–P17 (2016)CrossRef
4.
go back to reference I. Garin, F.M. Elli, A. Linglart, C. Silve, L. de Sanctis, P. Bordogna, A. Pereda, J.T.R. Clarke, C. Kannengiesser, R. Coutant, Y. Tenebaum-Rakover, O. Admoni, G.P. de Nanclares, G. Mantovani, Novel microdeletions affecting the GNAS locus in pseudohypoparathyroidism: characterization of the underlying mechanisms. J. Clin. Endocrinol. Metab. 100, E681–E687 (2015)CrossRef I. Garin, F.M. Elli, A. Linglart, C. Silve, L. de Sanctis, P. Bordogna, A. Pereda, J.T.R. Clarke, C. Kannengiesser, R. Coutant, Y. Tenebaum-Rakover, O. Admoni, G.P. de Nanclares, G. Mantovani, Novel microdeletions affecting the GNAS locus in pseudohypoparathyroidism: characterization of the underlying mechanisms. J. Clin. Endocrinol. Metab. 100, E681–E687 (2015)CrossRef
5.
go back to reference L.S. Weinstein, P.V. Gejman, E. Friedman, T. Kadowaki, R.M. Collins, E.S. Gershon, A.M. Spiegel, Mutations of the Gs alpha-subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis. Proc. Natl Acad. Sci. USA 87, 8287–8290 (1990)CrossRef L.S. Weinstein, P.V. Gejman, E. Friedman, T. Kadowaki, R.M. Collins, E.S. Gershon, A.M. Spiegel, Mutations of the Gs alpha-subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis. Proc. Natl Acad. Sci. USA 87, 8287–8290 (1990)CrossRef
6.
go back to reference F.M. Elli, L. deSanctis, B. Ceoloni, A.M. Barbieri, P. Bordogna, P. Beck-Peccoz, A. Spada, G. Mantovani, Pseudohypoparathyroidism type Ia and pseudo-pseudohypoparathyroidism: the growing spectrum of GNAS inactivating mutations. Hum. Mutat. (2013). https://doi.org/10.1002/humu.22265 CrossRef F.M. Elli, L. deSanctis, B. Ceoloni, A.M. Barbieri, P. Bordogna, P. Beck-Peccoz, A. Spada, G. Mantovani, Pseudohypoparathyroidism type Ia and pseudo-pseudohypoparathyroidism: the growing spectrum of GNAS inactivating mutations. Hum. Mutat. (2013). https://​doi.​org/​10.​1002/​humu.​22265 CrossRef
7.
go back to reference E. Fernandez-Rebollo, B. Garcia-Cuartero, I. Garin, C. Largo, F. Martinez, C. Garcia-Lacalle, L. Castano, M. Bastepe, G.P. de Nanclares, Intragenic GNAS deletion involving exon A/B in pseudohypoparathyroidism type 1A resulting in an apparent loss of exon A/B methylation: potential for misdiagnosis of pseudohypoparathyroidism type 1B. J. Clin. Endocrinol. Metab. 95, 765–771 (2010)CrossRef E. Fernandez-Rebollo, B. Garcia-Cuartero, I. Garin, C. Largo, F. Martinez, C. Garcia-Lacalle, L. Castano, M. Bastepe, G.P. de Nanclares, Intragenic GNAS deletion involving exon A/B in pseudohypoparathyroidism type 1A resulting in an apparent loss of exon A/B methylation: potential for misdiagnosis of pseudohypoparathyroidism type 1B. J. Clin. Endocrinol. Metab. 95, 765–771 (2010)CrossRef
8.
go back to reference T. Mitsui, K. Nagasaki, M. Takagi, S. Narumi, T. Ishii, T. Hasegawa, A family of pseudohypoparathyroidism type Ia with an 850-kb submicroscopic deletion encompassing the whole GNAS locus. Am. J. Med. Genet. A 158A, 261–264 (2012)CrossRef T. Mitsui, K. Nagasaki, M. Takagi, S. Narumi, T. Ishii, T. Hasegawa, A family of pseudohypoparathyroidism type Ia with an 850-kb submicroscopic deletion encompassing the whole GNAS locus. Am. J. Med. Genet. A 158A, 261–264 (2012)CrossRef
9.
go back to reference S.Y. Cho, Y.A. Yoon, C.-S. Ki, H.J. Huh, H.-W. Yoo, B.H. Lee, G.-H. Kim, J.-H. Yoo, S.-Y. Kim, S.J. Kim, Y.B. Sohn, S.W. Park, R. Huh, M.S. Chang, J. Lee, Y. Kwun, S.H. Maeng, D.-K. Jin, Clinical characterization and molecular classification of 12 Korean patients with pseudohypoparathyroidism and pseudopseudohypoparathyroidism. Exp. Clin. Endocrinol. Diabetes 121, 539–545 (2013)CrossRef S.Y. Cho, Y.A. Yoon, C.-S. Ki, H.J. Huh, H.-W. Yoo, B.H. Lee, G.-H. Kim, J.-H. Yoo, S.-Y. Kim, S.J. Kim, Y.B. Sohn, S.W. Park, R. Huh, M.S. Chang, J. Lee, Y. Kwun, S.H. Maeng, D.-K. Jin, Clinical characterization and molecular classification of 12 Korean patients with pseudohypoparathyroidism and pseudopseudohypoparathyroidism. Exp. Clin. Endocrinol. Diabetes 121, 539–545 (2013)CrossRef
10.
go back to reference R. Takatani, A. Molinaro, G. Grigelioniene, O. Tafaj, T. Watanabe, M. Reyes, A. Sharma, V. Singhal, F.L. Raymond, A. Linglart, H. Juppner, Analysis of multiple families with single individuals affected by pseudohypoparathyroidism type Ib (PHP1B) reveals only one novel maternally inherited GNAS deletion. J. Bone Miner. Res. 31, 796–805 (2016)CrossRef R. Takatani, A. Molinaro, G. Grigelioniene, O. Tafaj, T. Watanabe, M. Reyes, A. Sharma, V. Singhal, F.L. Raymond, A. Linglart, H. Juppner, Analysis of multiple families with single individuals affected by pseudohypoparathyroidism type Ib (PHP1B) reveals only one novel maternally inherited GNAS deletion. J. Bone Miner. Res. 31, 796–805 (2016)CrossRef
11.
go back to reference M. Reyes, A. Karaca, M. Bastepe, N.E. Gulcelik, H. Juppner, A novel deletion involving GNAS exon 1 causes PHP1A and further refines the region required for normal methylation at exon A/B. Bone 103, 281–286 (2017)CrossRef M. Reyes, A. Karaca, M. Bastepe, N.E. Gulcelik, H. Juppner, A novel deletion involving GNAS exon 1 causes PHP1A and further refines the region required for normal methylation at exon A/B. Bone 103, 281–286 (2017)CrossRef
14.
go back to reference F.M. Elli, A. Pereda, A. Linglart, G. Perez de Nanclares, G. Mantovani, Parathyroid hormone resistance syndromes—inactivating PTH/PTHrP signaling disorders (iPPSDs). Best Pract. Res. Clin. Endocrinol. Metab. 32, 941–954 (2018)CrossRef F.M. Elli, A. Pereda, A. Linglart, G. Perez de Nanclares, G. Mantovani, Parathyroid hormone resistance syndromes—inactivating PTH/PTHrP signaling disorders (iPPSDs). Best Pract. Res. Clin. Endocrinol. Metab. 32, 941–954 (2018)CrossRef
15.
go back to reference S. Thiele, R. Werner, W. Ahrens, A. Hbner, K.G. Hinkel, W. Hppner, B. Igl, O. Hiort, Selective deficiency of gs and the possible role of alternative gene products of GNAS in albright hereditary osteodystrophy and pseudohypoparathyroidism type Ia. Exp. Clin. Endocrinol. Diabetes (2010). https://doi.org/10.1055/s-0029-1215589 CrossRef S. Thiele, R. Werner, W. Ahrens, A. Hbner, K.G. Hinkel, W. Hppner, B. Igl, O. Hiort, Selective deficiency of gs and the possible role of alternative gene products of GNAS in albright hereditary osteodystrophy and pseudohypoparathyroidism type Ia. Exp. Clin. Endocrinol. Diabetes (2010). https://​doi.​org/​10.​1055/​s-0029-1215589 CrossRef
16.
go back to reference S. Thiele, R. Werner, J. Grötzinger, B. Brix, P. Staedt, D. Struve, B. Reiz, J. Farida, O. Hiort, A positive genotype-phenotype correlation in a large cohort of patients with pseudohypoparathyroidism type Ia and pseudo-pseudohypoparathyroidism and 33 newly identified mutations in the GNAS gene. Mol. Genet. Genom. Med. 3, 111–120 (2015)CrossRef S. Thiele, R. Werner, J. Grötzinger, B. Brix, P. Staedt, D. Struve, B. Reiz, J. Farida, O. Hiort, A positive genotype-phenotype correlation in a large cohort of patients with pseudohypoparathyroidism type Ia and pseudo-pseudohypoparathyroidism and 33 newly identified mutations in the GNAS gene. Mol. Genet. Genom. Med. 3, 111–120 (2015)CrossRef
Metadata
Title
A severe inactivating PTH/PTHrP signaling disorder type 2 in a patient carrying a novel large deletion of the GNAS gene: a case report and review of the literature
Authors
Alessandro Brancatella
Giovanna Mantovani
Francesca M. Elli
Simona Borsari
Claudio Marcocci
Filomena Cetani
Publication date
01-02-2020
Publisher
Springer US
Published in
Endocrine / Issue 2/2020
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-020-02195-7

Other articles of this Issue 2/2020

Endocrine 2/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine